LEADER 02408oam 22005294a 450 001 9910691794503321 005 20030910124204.0 035 $a(CKB)5470000002347445 035 $a(OCoLC)50126208 035 9 $aocm50126208 035 $a(OCoLC)995470000002347445 035 $a(EXLCZ)995470000002347445 100 $a20020705d2002 ua 0 101 0 $aeng 135 $aurunu---uuuun 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPrinciples of HIV prevention in drug-using populations$b[electronic resource] $ea research-based guide /$fNational Institute on Drug Abuse 210 1$a[Bethesda, MD] :$cNational Institute on Drug Abuse,$d[2002] 225 1 $aNIH publication ;$vno. 02-4733 300 $aTitle from title screen (viewed on Sept. 10, 2003). 300 $a"March 2002." 300 $aPrepared by Elizabeth Y. Lambert, et al. 320 $aIncludes bibliographical references. 330 $aThe National Institute on Drug Abuse (NIDA) has sponsored a comprehensive research program in response to the dynamic nature of the co-occurring epidemics of drug abuse and HIV/AIDS. This research has yielded a set of scientifically based principles for the use of community planners, policymakers, service providers, and medical practitioners as they develop and implement programs to prevent the spread of HIV and other infections among injecting and non-injecting drug users and their sexual partners. 517 $aPrinciples of HIV prevention in drug-using populations 606 $aHIV infections$xPrevention 606 $aDrug addicts$xDiseases$xPrevention 606 $aIntravenous drug abuse$xHealth aspects 606 $aHIV Infections$xprevention & control 606 $aSubstance-Related Disorders$xcomplications 607 $aUnited States 615 0$aHIV infections$xPrevention. 615 0$aDrug addicts$xDiseases$xPrevention. 615 0$aIntravenous drug abuse$xHealth aspects. 615 12$aHIV Infections$xprevention & control. 615 22$aSubstance-Related Disorders$xcomplications. 701 $aLambert$b Elizabeth Y$01384932 712 02$aNational Institute on Drug Abuse. 801 0$bNLM 801 1$bNLM 801 2$bGPO 906 $aBOOK 912 $a9910691794503321 996 $aPrinciples of HIV prevention in drug-using populations$93431808 997 $aUNINA